Test for Respiratory and Asthma Control in Kids (TRACK): A caregiver-completed questionnaire for preschool-aged children - 15/08/11
Abstract |
Background |
A validated questionnaire is needed to monitor respiratory control in preschool-aged children.
Objective |
We sought to develop and validate a caregiver-completed questionnaire that measures respiratory control in young children.
Methods |
A 33-item questionnaire that included asthma impairment and risk items was administered to 486 caregivers of children aged younger than 5 years with a current, recent, or past history of respiratory symptoms. Stepwise regression was used to select a subset of items with the greatest discriminant validity in relation to guidelines-defined asthma control in a random two-thirds development sample. Reliability, validity, and ability to screen for respiratory control problems were tested in development and validation samples (remaining one-third sample).
Results |
The content of the 5 items selected, the Test for Respiratory and Asthma Control in Kids (TRACK), included frequency of respiratory symptoms (wheeze, cough, shortness of breath), activity limitation, and nighttime awakenings in the past 4 weeks; rescue medication use in the past 3 months; and oral corticosteroid use in the previous year. Reliability was greater than 0.70 in both samples. ANOVA showed that mean scores differed significantly (P < .001) in the expected direction across both samples for 3 levels of guidelines-based respiratory control, physician-recommended change in therapy, and symptom status. In the development and validation samples, screening analyses revealed areas under the receiver operating characteristic curve of 0.88 and 0.82, respectively; control status was correctly classified in 81% and 78% of cases.
Conclusion |
TRACK is a valid, easy-to-administer, caregiver-completed questionnaire of respiratory control in preschool-aged children with symptoms consistent with asthma.
Le texte complet de cet article est disponible en PDF.Key words : Asthma, respiratory symptoms, asthma control, TRACK, validated questionnaire, asthma guidelines, young children
Abbreviations used : C-ACT, CFA, EFA, EPR-3, NAEPP, ROC, TRACK
Plan
Supported by AstraZeneca LP. |
|
Disclosure of potential conflict of interest: K. R. Murphy has received consulting honoraria from AstraZeneca, Schering-Plough, Merck, and Dey and has received research support from AstraZeneca, GlaxoSmithKline, Merck, Schering-Plough, and Novartis. R. S. Zeiger has served as a consultant for AstraZeneca. B. Chipps has received research support from Aventis, Genentech, AstraZeneca, GlaxoSmithKline, Novartis, Schering-Plough, Sepracor, and Merck; has received grants for educational activites from Alcon, Aventis, Genentech, AstraZeneca, GlaxoSmithKline, and Novartis; has served as an advisor for Alcon, Aventis, Genentech, AstraZeneca, GlaxoSmithKline, MedPoint, Novartis, Schering-Plough, Sepracor, and Merck; and has served on the speakers’ bureau for Alcon, Aventis, Genentech, AstraZeneca, Boehringer, GlaxoSmithKline, MedPoint, Novartis, Pfizer, Schering-Plough, Sepracor, and Merck. M. Mellon has served as a consultant for AstraZeneca and has served as a speaker for AstraZeneca and Schering-Plough. K. Lampl is employed by AstraZeneca. |
Vol 123 - N° 4
P. 833 - avril 2009 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?